Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
47 hedge funds and large institutions have $17.2M invested in Checkpoint Therapeutics in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 6
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
38% more call options, than puts
Call options by funds: $694K | Put options by funds: $503K
36% more capital invested
Capital invested by funds: $12.6M → $17.2M (+$4.6M)
4% more funds holding
Funds holding: 45 → 47 (+2)
1.1% more ownership
Funds ownership: 16.26% → 17.36% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$3.18M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$288K |
| 3 |
Morgan Stanley
New York
|
+$215K |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$185K |
| 5 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
+$180K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$493K |
| 2 |
Millennium Management
New York
|
-$84.3K |
| 3 |
HF
HRT Financial
New York
|
-$45K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$21.1K |
| 5 |
CL
Choreo LLC
Rockford,
Illinois
|
-$13.2K |
CKPT Hedge Fund Activity: Q3 2024 in Review
47 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q3 2024, worth a combined $17.2M — up 36% from $12.6M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CKPT positions and 4 closed out — a net gain of 3 holders — while 24 added to existing stakes and 6 trimmed.
The largest buyer was Armistice Capital, adding an estimated $3.18M. The largest seller was B. Riley Wealth Advisors, exiting entirely with an estimated $493K sold.
- 47 institutional investors held Checkpoint Therapeutics (CKPT) as of Q3 2024, up from 45 in Q2 2024.
- Funds reported $17.2M of Checkpoint Therapeutics stock for Q3 2024, up 36% quarter-over-quarter.
- 7 funds opened new Checkpoint Therapeutics positions in Q3 2024 and 4 closed out, a net change of +3 holders.
- The largest Checkpoint Therapeutics buyer in Q3 2024 was Armistice Capital, an estimated $3.18M added.
- The largest Checkpoint Therapeutics seller in Q3 2024 was B. Riley Wealth Advisors, an estimated $493K sold.
Based on aggregated 13F filings for Q3 2024.